The potential also exists that CXCR4 and CXCL12 expression may be regulated through beta adrenergic signaling, and beta blockade may prevent the expansion of hemangiosarcoma progenitor cells from the bone marrow or the migration of these cells to CXCL12-rich sites, reducing metastatic spread. This evidence concerns the gene CXCR4 and angiosarcoma.